Science

Crohn's disease, colon cancer, and yellow curry

SDPB Radio | By SDPB Staff

Published January 14, 2022 at 1:34 PM CST

Facebook
Twitter
LinkedIn
Email

These images show the binding power of the Ora-Curcumin S formulation in healthy mice (A) and those with ulcerative colitis (B). The red portions signify how the formulation attaches, or binds, to the sores or ulcers in inflamed colons. Through a National Institutes of Health grant, pharmaceutical sciences professor Hemachand Tummala will work with Dr. Amar B. Singh of the University of Nebraska Medical Center to do preclinical testing of the curcumin formulation.

The attached interview above is from SDPB's daily public-affairs show, In the Moment.

Professor Hemachand Tummala has secured a National Institutes of Health grant to do preclinical testing on a curcumin formulation designed to release its anti-inflammatory power in the colon.

Professor Hemachand Tummala, SDSU Department of Pharmaceutical Sciences, is looking for a localized treatment for chronic inflammation in the intestinal tract to help reduce the risk of colon cancer.

The project received a $433,000 National Institutes of Health grant to further this research in association with Dr. Amar B. Singh from the University of Nebraska Medical Center.

Colon cancer is the second-leading cause of cancer deaths among American men and women combined, according to the Center for Disease Control and Prevention. Ora-Curcumin S is a specialized formulation that is in pre-clinical trials. Curcumin is the main component in turmeric, the yellow spice that flavors Indian curry. It is a natural anti-inflammatory.

L earn more by clicking here.